Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The findings were reassuring enough that, in January 2026, the Food and Drug Administration (FDA) requested the removal of suicidal ideation and behavior warnings from the labels of GLP-1s, including Wegovy and Zepbound, after reviewing the available evidence
Sunscreen is essential
Current FDA labeling for semaglutide products includes warnings or precautions involving: Acute pancreatitis Acute gallbladder disease Acute kidney injury due to volume depletion Severe gastrointestinal reactions Hypoglycemia when combined with insulin or insulin secretagogues Diabetic retinopathy complications in susceptible patients Serious hypersensitivity reactions Pulmonary aspiration risk during general anesthesia or deep sedation Semaglutide labeling also contains a boxed warning regarding thyroid C-cell tumors observed in rodents
The future of obesity treatment is brighter than ever, and these medications are at the forefront
Studies have shown that Saxenda (liraglutide) is effective in reducing HbA1c levels and promoting weight loss in people with type 2 diabetes
But a new study, published in The American Journal of Psychiatry , evaluated the oral form of semaglutide, which researchers say may be more appealing to people with AUD than injectable versions that have previously been tested
US$ 29.05
US$ 24.06
US$ 25.72
US$ 24.54
US$ 29.04
